Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
23 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1 | 2016 | 2016 | ||||||
Neoplasms
|
1644 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.070 | 1.000 | 7 | 2011 | 2015 | |||||
Carcinogenesis
|
355 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||
Malignant Neoplasms
|
1641 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.020 | 1.000 | 2 | 2010 | 2015 | |||||
Neoplasm Metastasis
|
327 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.020 | 1.000 | 2 | 2010 | 2016 | |||||
Primary malignant neoplasm
|
1374 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.020 | 1.000 | 2 | 2010 | 2015 | |||||
Secondary Neoplasm
|
85 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.020 | 1.000 | 2 | 2010 | 2016 | |||||
Tumor Progression
|
72 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||
Adenocarcinoma
|
168 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Anaplastic thyroid carcinoma
|
16 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Colon Carcinoma
|
275 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Disseminated Malignant Neoplasm
|
4 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Follicular thyroid carcinoma
|
28 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Hypocholesterolemia
|
22 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Leukemia, T-Cell
|
10 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Lung Neoplasms
|
39 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of ovary
|
315 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant tumor of colon
|
688 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
ovarian neoplasm
|
757 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Pancreatic Neoplasm
|
20 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Patent ductus arteriosus
|
56 | 0.689 | 0.440 | 3 | 138759306 | missense variant | T/C | snv | 1.2E-05 | 0.010 | 1.000 | 1 | 2014 | 2014 |